Fintel reports that on November 4, 2025, Evercore ISI Group downgraded their outlook for Kimberly-Clark (NasdaqGS:KMB) from Outperform to In-Line. Analyst Price Forecast Suggests 38.22% Upside As of ...

While the canard that many mergers fail to provide a return to shareholders does not appear to be supported by the data, mergers still occur that appear to be motivated by little more than a CEO’s ...

At Holdings Channel, we have reviewed the latest batch of the 26 most recent 13F filings for the 09/30/2025 reporting period, and noticed that Kimberly-Clark Corp. (Symbol: KMB) was held by 15 of ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Kimberly-Clark KMB-13.99%decrease; red down pointing triangle has agreed to buy Kenvue KVUE 13.78%increase; green up pointing triangle for more than $40 billion, combining the maker of Huggies diapers ...

Kimberly-Clark Corporation (NASDAQ:KMB) rattled its shareholders when it earlier announced its acquisition of consumer goods giant Kenvue Inc (NYSE:KVUE). Ordinarily, such an acquisition might make ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common painkiller to autism,... Huggies maker Kimberly-Clark is buying Tylenol ...

Consumer giant Kimberly-Clark, which makes Huggies diapers and Kleenex tissues, is buying the company that makes Tylenol and Band-Aids in one of the biggest mergers of the year. The deal, worth almost ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

The maker of Tylenol is being sold to Kimberly-Clark in a $48.7 billion deal weeks after President Donald Trump and Health Secretary Robert F Kennedy Jr targeted the drug. Kimberly-Clark’s purchase of ...

Consumer-goods giant Kimberly-Clark Corp. announced Monday a deal to buy Kenvue Inc., ending months of speculation about the future of the embattled maker of Tylenol, Band-Aid and Listerine. Even ...